ArticleBlood science (Baltimore, Md.)2025

TREML2 enhances sensitivity of acute myeloid leukemia cells to chemotherapy by inhibiting the NF-κB/CXCL10 pathway.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.